eSight Wins CE Mark for Wearable to Enhance Vision

The Toronto-based company’s technology works by combining a camera and lens technology with advanced sensors and algorithms to maximize the quality of information sent to the brain, which in turn dramatically augments sight.

Omar Ford

August 11, 2020

2 Min Read
IMG_Aug112020at41003PM.jpg
Courtesy of eSight

eSight has won CE mark for a wearable assistive technology that can enhance vision for people living with low vision and legal blindness.

The device works for those living with visual acuities from 20/60 to 20/1400 (perfect vision is 20/20) caused by more than 20 different eye conditions including macular degeneration, diabetic retinopathy and Stargardt's disease. 

“Macular degeneration is a global phenomenon that millions of people suffer from,” Robert Vaters, esight’s president and CEO, told MD+DI. “We have the best product to help people navigate it.”

The Toronto-based company’s technology works by combining a camera and lens technology with advanced sensors and algorithms to maximize the quality of information sent to the brain, which in turn dramatically augments sight.

Wireless with built-in vision controls, the eSight 4 headset features an ergonomically designed halo band with a rechargeable battery that can be replaced within seconds for all-day comfort and use. eSight 4 is also cloud-based, so wearers are provided with easy and instant access to the latest features and invite loved ones and eSight support members to see what they are seeing and help manage their eSight experience.

Other key features of the device include advanced controls, allowing the user to control their vision with 24x zoom and a  bioptic tilt to maintain use of natural peripheral vision, and a new Apple and Android mobile apps that make it easier for people with low vision to see their smartphone screen in detail and watch content. 

Because of the impact of COVID-19, eSight had to forego a traditional launch of the product and instead move toward a virtual one.

“Traditionally, we would be present at conferences where there are physical people,” he said. “We would also have launch events in localities like for example Florida. It’s been a thing that everybody in every kind of business has had to adjust to. I think we’ve done quite a really good job because we were already in the process before COVID of doing demos online and working with our potential customers through the product remotely.”  

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like